T1	Participants 68 104	patients with low ejection fractions
T2	Participants 349 475	6797 patients with ejection fractions < or = 0.35 enrolled into the two Studies of Left Ventricular Dysfunction (SOLVD) trials
T3	Participants 647 785	Patients with heart failure entered the treatment trial (n = 2569) and those without heart failure entered the prevention trial (n = 4228)
T4	Participants 1757 1793	patients with low ejection fractions
